Morphine biotransformation genes and neonatal clinical factors predicted behaviour problems in very preterm children at 18 months. Chau CMY, Ross CJD, Chau V, Synnes AR, Miller SP, Carleton B, Grunau RE. EBioMedicine. 2019 Feb;40:655-662. doi: 10…

Treating women with opioid use disorder during pregnancy in Appalachia: Initial neonatal outcomes following buprenorphine + naloxone exposure. Nguyen L, Lander LR, O'Grady KE, Marshalek PJ, Schmidt A, Kelly AK, Jones HE. Am J Addict. 2018 Mar;27(2…

Impact of prenatal exposure to benzodiazepines and z-hypnotics on behavioral problems at 5 years of age: A study from the Norwegian Mother and Child Cohort Study. Sundbakk LM, Wood M, Gran JM, Nordeng H (2019)  PLoS ONE 14(6): e0217830. doi.o…

Parent's experiences of their child's withdrawal syndrome: a driver for reciprocal nurse-parent partnership in withdrawal assessment. Craske J, Carter B, Jarman I, Tume L. Intensive Crit Care Nurs. 2019 Feb;50:71-78. doi: 10.1016/j.iccn.2018.09.00…

Therapeutic approaches for neonatal abstinence syndrome: a systematic review of randomized clinical trials. Ghazanfarpour M, Najafi MN, Roozbeh N, Mashhadi ME, Keramat-Roudi A, Mégarbane B, Tsatsakis A, Moghaddam MMM, Rezaee R. Daru. 2019 May 15…

In utero exposure to norbuprenorphine, a major metabolite of buprenorphine, induces fetal opioid dependence and leads to neonatal opioid withdrawal syndrome. Griffin BA, Caperton CO, Russell LN, Cabalong CV, Wilson CD, Urquhart KR, Martins BS, Zita…